Inj daunorubicin, cytarabine
Products billed under this code include Vyxeos.
Payment limit per 1 MG/2.27 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J9153
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Vyxeos | Jazz Pharmaceuticals, Inc. | 68727-0745-02 | 88 | $24,138.40 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $274.30 | +$1.414 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted September 17, 2026 |
| 3Q26 | $272.886 | +$11.691 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted September 15, 2026 |
| 2Q26 | $261.195 | +$0.705 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted September 15, 2026 |
| 1Q26 | $260.49 | +$4.403 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted September 15, 2026 |
| 4Q25 | $256.087 | +$0.995 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted September 8, 2026 |
| 3Q25 | $255.092 | +$6.071 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted March 10, 2026 |
| 2Q25 | $249.021 | +$0.611 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted March 10, 2026 |
| 1Q25 | $248.41 | +$5.915 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted December 19, 2025 |
| 4Q24 | $242.495 | +$0.886 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted June 11, 2025 |
| 3Q24 | $241.609 | +$8.806 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted June 11, 2025 |
| 2Q24 | $232.803 | +$1.039 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted March 11, 2025 |
| 1Q24 | $231.764 | +$3.828 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted December 19, 2024 |
| 4Q23 | $227.936 | +$0.704 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted October 10, 2024 |
| 3Q23 | $227.232 | +$8.091 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted June 5, 2024 |
| 2Q23 | $219.141 | +$0.084 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted February 23, 2024 |
| 1Q23 | $219.057 | +$3.838 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted December 6, 2023 |
| 4Q22 | $215.219 | −$0.188 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted June 22, 2023 |
| 3Q22 | $215.407 | +$2.578 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted June 9, 2023 |
| 2Q22 | $212.829 | +$5.198 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted December 14, 2022 |
| 1Q22 | $207.631 | +$5.035 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted June 8, 2022 |
| 4Q21 | $202.596 | −$0.213 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted June 2, 2022 |
| 3Q21 | $202.809 | +$0.17 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted June 2, 2022 |
| 2Q21 | $202.639 | +$0.953 | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted March 1, 2022 |
| 1Q21 | $201.686 | – | 1 MG/2.27 MG | Inj daunorubicin, cytarabine | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024
- 2Q23: 2024-02-23_april-2023-asp-pricing-file.zipposted February 23, 2024
- 1Q23: 2023-12-06_january-2023-asp-pricing-file.zipposted December 6, 2023
- 4Q22: 2023-06-22_october-2022-asp-pricing-file.zipposted June 22, 2023
- 3Q22: 2023-06-09_july-2022-asp-pricing-file.zipposted June 9, 2023
- 2Q22: 2022-12-14_april-2022-asp-pricing-file.zipposted December 14, 2022
- 1Q22: 2022-06-08_january-2022-asp-pricing-file.zipposted June 8, 2022
- 4Q21: 2022-06-02_october-2021-asp-pricing-file.zipposted June 2, 2022
- 3Q21: 2022-06-02_july-2021-asp-pricing-file.zipposted June 2, 2022
- 2Q21: 2022-03-01_april-2021-asp-pricing-file.zipposted March 1, 2022
- 1Q21: 2021-12-10_january-2021-asp-pricing-file.zipposted December 10, 2021